Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Overexpression of Mir-21-5p Induces Apoptosis and Cell Cycle Arrest By Down-Regulating SKP2 and Overcomes Bortezomib Resistance in Multiple Myeloma

Jonahunnatha Nesson George William, PhD, Jian Wu, MD, Ziyan Chen, Omar Faruq, PhD, Hong Chang, MD

Blood (2019) 134 (Supplement_1): 1823.

https://doi.org/10.1182/blood-2019-128917

Published: 2019

Journal Articles

Critical Role for Apobec and Its Interacting Partners in Mediating Mutations and Cell Growth in Multiple Myeloma (MM)

Srikanth Talluri, PhD, Mehmet Kemal Samur, PhD, Jialan Shi, MD PhD, Rao Prabhala, PhD, Hervé Avet-Loiseau, MD PhD, Masood A. Shammas, PhD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 4462.

https://doi.org/10.1182/blood-2018-99-118441

Published: 2018

Journal Articles

IL-7 Activates a STAT5/PIM1 Axis to Promote T-Cell Acute Lymphoblastic Leukemia Proliferation and Viability in a Bcl-2-Independent Manner

Ribeiro Daniel, PhD, Alice Melão, Msc, Ruben van Boxtel, PhD, Cristina Santos, PhD, Ana Silva, PhD, Milene C Silva, PhD, Bruno António Cardoso, PhD, Paul J. Coffer, PhD Prof, Joao Barata, PhD

Blood (2018) 132 (Supplement 1): 914.

https://doi.org/10.1182/blood-2018-99-113778

Published: 2018

Journal Articles

Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence

Pei-Hsuan Chen, PhD, Mikel Lipschitz, M.S., Kyle Wright, MD, PhD, Philippe Armand, MD PhD, Caron A. Jacobson, MD MMSc, Zachary J. Roberts, MD, PhD, John M. Rossi, MS, Adrian Bot, MD PhD, William Y. Go, MD PhD, Scott J Rodig, MD

Blood (2018) 132 (Supplement 1): 678.

https://doi.org/10.1182/blood-2018-99-113644

Published: 2018

Journal Articles

Dexamethasone Accelerates the Transition of Human BFU-E to CFU-E and Enhances CFU-E Proliferation through Cell Cycle Regulation

Ryan Ashley, BS, MS, Hongxia Yan, MS, Brian Dulmovits, BA, MS, Nan Wang, PhD, Julien Papoin, MS, Jeffrey M Lipton, MD PhD, Mohandas Narla, DSc, Anupama Narla, MD, Lionel Blanc, PhD

Blood (2018) 132 (Supplement 1): 3620.

https://doi.org/10.1182/blood-2018-99-116596

Published: 2018

Journal Articles

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation

Blood (2018) 132 (Supplement 1): 4609.

https://doi.org/10.1182/blood-2018-99-115457

Published: 2018

Journal Articles

The Effect of the Proteasome Inhibitor Ixazomib (MLN9708) and UPR Mediated Therapy in Multiple Myeloma Cells and Bone Marrow Niche

Azam Salimi, MSc, Kema Marlen Schroeder, Margherita Vieri, Tim H. Brümmendorf, MD, Iris Appelmann, Behzad Kharabi

Blood (2017) 130 (Supplement 1): 5362.

https://doi.org/10.1182/blood.V130.Suppl_1.5362.5362

Published: 2017

Journal Articles

EBV latent membrane protein 2A orchestrates p27 kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice

Kamonwan Fish, Richard P. Sora, Samantha J. Schaller, Richard Longnecker, Masato Ikeda

Blood (2017) 130 (23): 2516–2526.

https://doi.org/10.1182/blood-2017-07-796821

Published: 2017

Includes: Supplemental data

Journal Articles

FOXtrotting with PUMILIOs

Arefeh Rouhi, Florian Kuchenbauer

Blood (2017) 129 (18): 2459–2460.

https://doi.org/10.1182/blood-2017-03-771469

Published: 2017

Journal Articles

Marcks Peptide Inhibitor Displays Synergistic Cytotoxicity with Bortezomib in Drug Resistant Multiple Myeloma Cells but Enhances Autophagic Effect

Lun Zhang, PhD, Jahangir Abdi, PhD, Minjing Wang, Nasrin Rastgoo, PhD, Hong Chang, MD PhD

Blood (2016) 128 (22): 2061.

https://doi.org/10.1182/blood.V128.22.2061.2061

Published: 2016

Journal Articles

Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma

Fengyan Jin, MD PhD, Shuang Li, MD, Lijuan Chen, PhD, Chuan Wu, MD, Wei Li, MD, Jian Hou, MD, Yun Dai, MD PhD

Blood (2016) 128 (22): 2125.

https://doi.org/10.1182/blood.V128.22.2125.2125

Published: 2016

Journal Articles

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

Nicola Lehners, MD, Elena Ellert, MD, Jing Xu, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 4474.

https://doi.org/10.1182/blood.V128.22.4474.4474

Published: 2016

Journal Articles

p19 INK4d Modulates Human Terminal Erythroid Differentiation By Post-Transcriptionally Regulating GATA1 Expression

Xu Han, Jieying Zhang, Yuanliang Peng, Huiyong Chen, PhD, Xiao Chen, Yibin Zhang, Xiao Hu, PhD, Narla Mohandas, Xiuli An, MD PhD, Jing Liu, PhD

Blood (2016) 128 (22): 697.

https://doi.org/10.1182/blood.V128.22.697.697

Published: 2016

Journal Articles

Loss of the TLE4 AML Tumor Suppressor Gene Contributes to Leukemic Cell Proliferation, Differentiation Arrest, and Chemotherapy Resistance through a COX-Dependent Inflammatory Pathway

Thomas H Shin, David A Sweetser, MD,PhD

Blood (2015) 126 (23): 1241.

https://doi.org/10.1182/blood.V126.23.1241.1241

Published: 2015

Journal Articles

A Novel Regulatory Region of the p27 Locus Is Required for Normal Erythroid p27 Expression, and Produces a Long Noncoding RNA with No Detectable Function

Vikram R Paralkar, MD, Cristian Taborda, Yu Yao, MD, Rishi Prasad, Jing Luan, Ross C. Hardison, PhD, Gerd A. Blobel, MD PhD, Mitchell J Weiss, MD PhD

Blood (2015) 126 (23): 1175.

https://doi.org/10.1182/blood.V126.23.1175.1175

Published: 2015

Journal Articles

Balancing Proliferation, Differentiation, and Survival: Powerful Genetic and RNAi Technologies Reveal Essential microRNA Signaling for Leukemic Progenitor Cell Fitness

Sara E. Meyer, PhD, Emily Orr, Andrew M. Rogers, MS,MD, John G Doench, PhD, Bruce J. Aronow, PhD, Ashish Lal, PhD, Edwina McGlinn, PhD, H. Leighton Grimes, PhD

Blood (2015) 126 (23): 441.

https://doi.org/10.1182/blood.V126.23.441.441

Published: 2015

Journal Articles

Sphingosine Kinases (SK): Key Molecules Associated with the Activation, Proliferation and Ibrutinib-Induced Cell Death of Chronic Lympocytic Leukemia Cells

Maria Belen Almejun, PhD, Mercedes Borge, PhD, Ana Colado, Enrique Podaza, Denise Risnik, Carlos Daniel De Brasi, Pablo Oppezzo, PhD, Maria Cabrejo, MD, Horacio Fernandez Grecco, MD, Raimundo F. Bezares, MD, Santiago C Cranco, MD, Ruben A. Burgos, MD, Julio Cesar Sanchez Avalos, MD, Mirta N. Giordano, PhD, Romina Gamberale, PhD

Blood (2015) 126 (23): 1714.

https://doi.org/10.1182/blood.V126.23.1714.1714

Published: 2015

Journal Articles

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

Alexander Hoellein, MD, Stephanie Schoeffmann, Fallahi Mohammad, PhD, John L Cleveland, PhD, Johannes Gloeckner, PhD, Marius Ueffing, PhD, Martina Rudelius, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 3107.

https://doi.org/10.1182/blood.V124.21.3107.3107

Published: 2014

Journal Articles

ETV6/ARG Oncoprotein Induces Autonomous Cell Growth By Enhancing c-Myc Expression through STAT5 Activation in the Acute Promyelocytic Leukemia Cell Line HT93A

Noriyoshi Iriyama, MD PhD, Yoshihiro Hatta, MD, Masami Takei, MD PhD

Blood (2014) 124 (21): 5955.

https://doi.org/10.1182/blood.V124.21.5955.5955

Published: 2014

Journal Articles

PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways

Valter Agosti, MD PhD, Daniela Talarico, Agostina Urzino, Raghavendra Vasudeva Murthi, PhD, Aurora Anna Rita Nocera, PhD, Emilia Dora Giovannone

Blood (2014) 124 (21): 5211.

https://doi.org/10.1182/blood.V124.21.5211.5211

Published: 2014

NARROW

Overexpression of Mir-21-5p Induces Apoptosis and Cell Cycle Arrest By Down-Regulating SKP2 and Overcomes Bortezomib Resistance in Multiple Myeloma

Critical Role for Apobec and Its Interacting Partners in Mediating Mutations and Cell Growth in Multiple Myeloma (MM)

IL-7 Activates a STAT5/PIM1 Axis to Promote T-Cell Acute Lymphoblastic Leukemia Proliferation and Viability in a Bcl-2-Independent Manner

Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence

Dexamethasone Accelerates the Transition of Human BFU-E to CFU-E and Enhances CFU-E Proliferation through Cell Cycle Regulation

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation

The Effect of the Proteasome Inhibitor Ixazomib (MLN9708) and UPR Mediated Therapy in Multiple Myeloma Cells and Bone Marrow Niche

EBV latent membrane protein 2A orchestrates p27 kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice

FOXtrotting with PUMILIOs

Marcks Peptide Inhibitor Displays Synergistic Cytotoxicity with Bortezomib in Drug Resistant Multiple Myeloma Cells but Enhances Autophagic Effect

Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

p19 INK4d Modulates Human Terminal Erythroid Differentiation By Post-Transcriptionally Regulating GATA1 Expression

Loss of the TLE4 AML Tumor Suppressor Gene Contributes to Leukemic Cell Proliferation, Differentiation Arrest, and Chemotherapy Resistance through a COX-Dependent Inflammatory Pathway

A Novel Regulatory Region of the p27 Locus Is Required for Normal Erythroid p27 Expression, and Produces a Long Noncoding RNA with No Detectable Function

Balancing Proliferation, Differentiation, and Survival: Powerful Genetic and RNAi Technologies Reveal Essential microRNA Signaling for Leukemic Progenitor Cell Fitness

Sphingosine Kinases (SK): Key Molecules Associated with the Activation, Proliferation and Ibrutinib-Induced Cell Death of Chronic Lympocytic Leukemia Cells

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

ETV6/ARG Oncoprotein Induces Autonomous Cell Growth By Enhancing c-Myc Expression through STAT5 Activation in the Acute Promyelocytic Leukemia Cell Line HT93A

PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only